# reload+after+2024-01-23 09:44:24.174700
address1§301 Carlson Parkway
address2§Suite 210
city§Minneapolis
state§MN
zip§55305
country§United States
phone§763 496 5454
website§https://www.diamedica.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. The company develops treatments for neurological disorders and cardio-renal disease. Its lead candidate is DM199, a pharmaceutically active recombinant form of the kallikrein-1 protein for the treatment of acute ischemic stroke and other vascular diseases. It is also developing DM300 that is in preclinical stage of development for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
fullTimeEmployees§16
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Dietrich John Pauls MBA', 'age': 52, 'title': 'President, CEO & Director', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 736788, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Scott  Kellen CPA', 'age': 58, 'title': 'CFO & Company Secretary', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 447025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Kirsten L. Gruis M.D., M.S.', 'age': 50, 'title': 'Independent Consultant', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 519815, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ambarish  Shah Ph.D.', 'title': 'Chief Technology Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Dominic R. Cundari', 'age': 72, 'title': 'Chief Commercial Officer', 'yearBorn': 1951, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Julie VanOrsdel Daves CCRP', 'title': 'Senior VP of Clinical Development Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David J. Wambeke', 'title': 'Chief Business Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jordan S. Dubow M.D.', 'age': 45, 'title': 'Chief Medical Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.776
currency§USD
dateShortInterest§1702598400
forwardEps§-0.67
pegRatio§-0.16
exchange§NCM
quoteType§EQUITY
shortName§DiaMedica Therapeutics Inc.
longName§DiaMedica Therapeutics Inc.
firstTradeDateEpochUtc§1344000600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§b3b6442c-de29-30ba-912e-479d62e5fd59
gmtOffSetMilliseconds§-18000000
targetHighPrice§11.0
targetLowPrice§7.0
targetMeanPrice§8.33
targetMedianPrice§7.0
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§3
quickRatio§21.555
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
